Vimarsana
Biggest News Aggregation in the World

Page 43 - Harbor Statement News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Harbor Statement. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Harbor Statement Today - Breaking & Trending Today

Intercontinental Exchange Announces 7% Increase to its Quarterly Dividend - Vimarsana News

Intercontinental Exchange Announces 7% Increase to its Quarterly Dividend

Intercontinental Exchange , a leading global provider of data, technology, and market infrastructure, announced board authorization of its first quarter 2024 dividend of $0.45 per share, up 7% from...

Intercontinental Exchange Reports Strong Full Year 2023 Results - Vimarsana News

Intercontinental Exchange Reports Strong Full Year 2023 Results

18th consecutive year of record revenues ...

Branded Legacy, Inc. Expands Operations with Move to State of the Art Biotech Facility in Melbourne, FL - Vimarsana News

Branded Legacy, Inc. Expands Operations with Move to State of the Art Biotech Facility in Melbourne, FL

White Label Deal Secured, 1,700,000 Preferred Series Shares Repurchased and Retired MELBOURNE, Fla., Feb. 8, 2024 /PRNewswire/ -- , a prominent Biotech company, proudly announces a significant leap...

Arrowhead Pharmaceuticals Reports Fiscal 2024 First Quarter Results - Vimarsana News

Arrowhead Pharmaceuticals Reports Fiscal 2024 First Quarter Results

- Conference Call and Webcast Today, February 6, 2024, at 4:30 p.m. ETPASADENA, Calif.--(BUSINESS WIRE)--$arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal 2024 first quarter ended December 31, 2023. The Company is hosting a conference call today, February 6, 2024,...

Enlivex Announces Issuance of New U.S. Patent Covering Allocetra Cells and Their Manufacturing Method - Vimarsana News

Enlivex Announces Issuance of New U.S. Patent Covering Allocetra Cells and Their Manufacturing Method

Nes-Ziona, Israel, Feb. 07, 2024 -- Enlivex Therapeutics Ltd., , a clinical-stage macrophage reprogramming immunotherapy company, today announced that the U.S. Patent and Trademark Office issued a...